Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Chronic Idiopathic Urticaria
NCT01030120Phase 3Withdrawn
- Sponsor
- University of Utah
- Start
- Dec 2010
- Primary completion
- Jul 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in chronic idiopathic urticaria (CIU), sponsored by University of Utah. Planned start Dec 2010; status: withdrawn.
02
Drugs
etanercept
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT01030120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01030120.